Huntington Bancshares Incorporated
Huntington Bancshares Incorporated sells banking and financial services to consumers, small businesses, middle-market companies, public sector entities, and commercial real estate clients via physical branches, digital channels, and relationship managers by providing deposit accounts, loans (including commercial, industrial, and auto), payment processing, wealth management, insurance, leasing, and trust services; it also cross-sells fee-based products and leverages partnerships to deepen customer relationships.
LOCKED
Market: NormalKey Catalysts & Risks
The most consequential catalyst is the Cadence integration: the legal combination closed in early 2026 and management has pointed to a systems conversion around mid-2026, with cost synergies plus a phased ramp in revenue synergies that is expected to build through 2027 and beyond, so successful conversion and deposit retention would validate the deal thesis while slippage would pressure both earnings and management credibility. A second catalyst is the trajectory of net interest margin and organic loan growth; management lowered its 2027 earnings outlook at the Barclays conference, citing higher-for-longer rates, deposit price competition and faster commercial real estate paydowns, and the main upside would come from an easing rate path or better deposit pricing while the downside is a prolonged flat margin. Third, capital return has become a more visible driver, with management materially increasing planned share repurchases for the current year and signalling a larger programme for 2027 as slower loan growth frees capital, which can support per-share metrics if credit holds. The build-out of the North and South Carolina branch network and the scaling of payments, wealth and capital markets fee businesses are slower-burn initiatives that could shift the revenue mix toward less rate-sensitive income over the next 12 to 36 months. The direction of all of these is mixed rather than clearly positive, which is consistent with a stock whose re-rating depends on execution being proven rather than on a single discrete event.
The clearest structural exposure is credit concentration: the loan book carries meaningful commercial real estate and indirect auto exposure, and company disclosures show automobile net charge-offs rising and commercial real estate paydowns accelerating, which makes the earnings base more sensitive to a consumer or property downturn even though overall loss rates remain modest. The revenue model is also heavily weighted to spread income, making profitability structurally dependent on deposit pricing and rate conditions, and management has acknowledged unusual competition for deposits and loans with a margin it does not expect to improve much on its own. Management frames both as manageable, pointing to tightened underwriting and deliberately reduced auto production rather than price-chasing, and there is no evidence in filings or regulator documents of a licence-to-operate or governance problem. The practical implication for the equity is that returns and capital generation may be more cyclical and more contingent on integration execution than the longer-range targets imply.
Research refreshed: 2nd of October 2026
KPIs and Peer Benchmarks
| EV | P/E | Net Debt/EBIT | Revenue Growth | |
|---|---|---|---|---|
| Citizens Fi… (CFG) | 30.8B | 13.86 | 1.32 | -9.7% |
| First Citiz… (FCNCA) | 54.1B | 11.01 | 9.71 | -3.0% |
| Fifth Third… (FITB) | 64B | 17.19 | 5.98 | -1.4% |
| KeyCorp (KEY) | 34.6B | 11.61 | 6.84 | 23.6% |
| M&T Bank Co… (MTB) | 48B | 11.56 | 3.94 | -8.2% |
| The PNC Fin… (PNC) | 145B | 12.16 | 6.07 | 0.8% |
| Regions Fin… (RF) | 20.8B | 10.93 | -0.81 | 2.5% |
| Truist Fina… (TFC) | 123B | 10.53 | 9.57 | 25.5% |
| U.S. Bancorp (USB) | 119B | 11.48 | 2.82 | 0.3% |
| Huntington … (HBAN) | 49.5B | 11.27 | 6.31 | 4.4% |
AI Opinion
Fundamentals
BUY: Completed Cadence conversion shifts the investment case toward measurable earnings execution. Q2 organic loans grew 1.2% sequentially, deposits 1.8%, and organic value-added fees approximately 30% year over year. These call disclosures strengthen the otherwise mixed fundamentals, but acquisition-driven growth and dilution require confirmation through improving EPS and operating leverage.
Peer Comparison
Peer-implied fair value of $18.07 offers 19.0% price upside from $15.19, but HBAN ranks above only approximately 44% of peers on combined growth and quality. Call-reported adjusted ROTCE of 17.5% provides more bank-relevant profitability evidence than generic ROIC and FCF ratios. Use peer valuation as the principal anchor; reject the guarded $30.38 historical EV-to-sales estimate as a credible 12-month target.
Macro Environment
Lower short-term rates could ease funding costs, but the call's 6 bps sequential increase in deposit costs demonstrates that relief is not automatic; management's earlier possible-hike assumptions also differ from the supplied August rate backdrop. The 5.29% 10-year yield and weak consumer sentiment threaten borrower affordability, CRE refinancing and valuation recovery. Resilient employment and industrial activity support commercial demand contextually, while company-specific deposit optimization and asset repricing matter more than weak financial-sector momentum.
Key Metrics
Trailing dividend yield is 4.1%; price is approximately 7.9-8.0 times management's unproven 2027 EPS objective of $1.90-$1.93. Q2 adjusted ROTCE was 17.5%, versus a 2027 target of 18%-19%. Monitor Q4 NIM reaching the mid-to-high 320 bps range, core efficiency near 54%, $435M combined run-rate synergies and actual EPS growth. Reported 4.65% ROIC and 27.61% FCF margin are secondary to bank-specific returns, funding, credit and capital measures.
Insider Activity
No trades in the last 30 days provide no fresh signal. Approximately $6.29M net selling across older windows and Kowalski's 26.7% position reduction warrant modest caution; mixed director activity, small relative CEO buying and some 10b5-1 sales limit conviction in a bearish interpretation.
Income Statement
Q2 net income rose 35.63% to $727M, yet diluted EPS slipped to $0.33 from $0.34 as shares expanded substantially. TTM expenses grew 34.19% versus revenue growth of 26.44%, the strongest disconfirming signal. Adjusted PPNR growth of 12% sequentially and strong organic fee growth support recovery, but NII guidance is at the low end or modestly below its prior range. Q4 synergy capture and a targeted approximately 54% core efficiency ratio must translate into stronger per-share earnings.
Cash Flow
TTM operating cash flow of $3.062B and provider-defined FCF of $2.683B exceed approximately $2.4B net income and support reported distributions. Quarterly working-capital and non-cash swings reduce interpretability, and bank FCF does not establish regulatory distribution capacity. Management plans at least $550M of 2026 buybacks and $1.1B-$1.2B in 2027; these can support EPS but are modest relative to acquisition-related dilution.
Balance Sheet
Reported equity of $32.624B and cash plus short-term investments of $51.250B provide support, although cash alone was $16.044B and regulatory capital ratios remain unavailable. The call adds evidence of organic deposit growth exceeding loan growth, reduced wholesale/broker funding and approximately 80% retention of maturing Cadence CDs. Elevated NPAs, selected commercial-credit downgrades and acquired CRE exposure remain risks; management expects charge-offs in the lower half of its 25-35 bps range.